Fig. 2From: Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort studyThe relative dose intensity of oxaliplatin (RDI-O) ≥60 vs < 60% and early recurrence in the whole group within 12, 18 and 36 monthsBack to article page